Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database-Reference-Cited by-同舟云学术

Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database

Published:2022-05-01 Issue:5 Volume:158 Page:513
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Pina Vegas Laura¹²,Penso Laetitia¹³,Claudepierre Pascal¹²,Sbidian Emilie¹⁴⁵

Affiliation:

1. EpiDermE, Université Paris Est Créteil, Créteil, France

2. Service de Rhumatologie, Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Henri Mondor, Créteil, France

3. EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, St Denis

4. Institut National de la Santé et de la Recherche Médicale, Centre d’Investigation Clinique 1430, Hôpital Henri Mondor, Créteil, France

5. Service de Dermatologie, AP-HP, Hôpital Henri Mondor, Créteil, France

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2790084/jamadermatology_pina_vegas_2022_oi_220010_1652203159.23953.pdf

Reference55 articles.

1. Psoriasis.;Boehncke;Lancet,2015

2. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.;Parisi;BMJ,2020

3. Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the “OBJECTIFS PEAU” study.;Richard;J Eur Acad Dermatol Venereol,2018

4. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies.;Alinaghi;J Am Acad Dermatol,2019

5. The epidemiology of psoriatic arthritis.;Ogdie;Rheum Dis Clin North Am,2015

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling multifaceted roles of myeloid innate immune cells in the pathogenesis of psoriasis;Molecular Aspects of Medicine;2024-10

2. The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target;Expert Opinion on Biological Therapy;2024-09-08

3. Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational Strategy;Rheumatology and Therapy;2024-08-12

4. Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS);RMD Open;2024-08

5. Real-World Drug Survival of Biologics and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs Among Patients with Psoriatic Arthritis;Drugs & Aging;2024-08